Clinical Trial Update: Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LBSA0103 to Hyruan Plus Injection in knee osteoarthritis evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Hyruan Plus Injection (Sodium hyaluronate)
• LBSA0103

Snippet

Sponsor: LG Life Sciences | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED